A detailed history of St. Louis Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, St. Louis Trust CO holds 687 shares of LLY stock, worth $546,625. This represents 0.09% of its overall portfolio holdings.

Number of Shares
687
Previous 992 30.75%
Holding current value
$546,625
Previous $898,000 32.29%
% of portfolio
0.09%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $235,502 - $292,806
-305 Reduced 30.75%
687 $608,000
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $180,621 - $241,645
305 Added 44.4%
992 $771,000
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $220,904 - $257,398
687 New
687 $251,000
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $191,487 - $224,834
687 New
687 $223,000
Q3 2018

Oct 31, 2018

SELL
$85.86 - $107.31 $751,189 - $938,855
-8,749 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$75.7 - $86.88 $662,299 - $760,113
8,749 New
8,749 $747,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track St. Louis Trust CO Portfolio

Follow St. Louis Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Louis Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on St. Louis Trust CO with notifications on news.